The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
116838783 11683878 3 F 20020918 20160714 20151029 20160722 EXP US-009507513-1510USA014300 MERCK 0.00 M Y 89.34000 KG 20160722 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
116838783 11683878 1 PS PROSCAR FINASTERIDE 1 Oral 5 MG, UNK 20180 5 MG FILM-COATED TABLET
116838783 11683878 2 SS FINASTERIDE. FINASTERIDE 1 Unknown 5 MG, UNK U U 0 5 MG
116838783 11683878 3 C TERAZOSIN TERAZOSINTERAZOSIN HYDROCHLORIDE 1 Unknown UNK U U 0
116838783 11683878 4 C TERAZOSIN TERAZOSINTERAZOSIN HYDROCHLORIDE 1 U U 0
116838783 11683878 5 C MONOPRIL FOSINOPRIL SODIUM 1 Unknown UNK U U 0
116838783 11683878 6 C GLYBURIDE. GLYBURIDE 1 Unknown UNK U U 0
116838783 11683878 7 C RHINOCORT (beclomethasone dipropionate) BECLOMETHASONE DIPROPIONATE 1 Nasal UNK U U 0
116838783 11683878 8 C RHINOCORT (beclomethasone dipropionate) BECLOMETHASONE DIPROPIONATE 1 U U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
116838783 11683878 1 Benign prostatic hyperplasia
116838783 11683878 2 Benign prostatic hyperplasia
116838783 11683878 3 Hypertension
116838783 11683878 4 Benign prostatic hyperplasia
116838783 11683878 5 Hypertension
116838783 11683878 6 Type 2 diabetes mellitus
116838783 11683878 7 Hypersensitivity
116838783 11683878 8 Sinus disorder

Outcome of event

Event ID CASEID OUTC COD
116838783 11683878 HO
116838783 11683878 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
116838783 11683878 Anxiety
116838783 11683878 Balanoposthitis
116838783 11683878 Bladder neck obstruction
116838783 11683878 Cerebrovascular accident
116838783 11683878 Condition aggravated
116838783 11683878 Drug ineffective
116838783 11683878 Erectile dysfunction
116838783 11683878 Facial paralysis
116838783 11683878 Gastrooesophageal reflux disease
116838783 11683878 Hypertriglyceridaemia
116838783 11683878 Infection
116838783 11683878 Inflammation
116838783 11683878 Myalgia
116838783 11683878 Pain
116838783 11683878 Paraesthesia
116838783 11683878 Paraesthesia oral
116838783 11683878 Paranoia
116838783 11683878 Phimosis
116838783 11683878 Premature ejaculation
116838783 11683878 Prostate cancer
116838783 11683878 Prostatic dysplasia
116838783 11683878 Prostatitis
116838783 11683878 Sexual dysfunction
116838783 11683878 Stress urinary incontinence
116838783 11683878 Transient ischaemic attack
116838783 11683878 Vertigo

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
116838783 11683878 1 20010706 200702 0
116838783 11683878 3 20010110 200901 0
116838783 11683878 5 20010110 200407 0
116838783 11683878 6 20010116 200609 0
116838783 11683878 7 20010426 200305 0